Veramyst FDA Approval History

FDA Approved: Yes (Discontinued) (First approved April 27, 2007)
Brand name: Veramyst
Generic name: fluticasone furoate
Dosage form: Nasal Spray
Company: GlaxoSmithKline
Treatment for: Allergic Rhinitis

Marketing Status: Discontinued

Veramyst (fluticasone furoate) is an intranasal corticosteroid administered once-daily for the treatment of seasonal and year- round allergy symptoms in adults and children two years of age and older.

On August 2, 2016, the FDA announced the approval of Flonase Sensimist Allergy Relief (fluticasone furoate, 27.5 mcg spray) as an over-the-counter (OTC) replacement for the prescription product Veramyst.

Development timeline for Veramyst

Date	Article
Apr 29, 2007	Approval FDA Approves Once-Daily Veramyst (fluticasone furoate) Nasal Sprayfor Treatment of Seasonal and Year-Round Allergy Symptoms in Adultsand Children as Young as Two Years
Jul 27, 2006	New Seasonal and Perennial Rhinitis Intranasal Treatment Submitted for U.S. and European Marketing Approval

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer